He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams. Chapters Intro and early life – 0:39 MD / PhD at Stanford – 5:10 Intro to venture – 9:39 Joining Sofinnova – 13:32 Product vs platform – 20:55 Board seats – 26:00 Investment strategy – 30:08 Therapeutic areas – 39:42 Regulatory predictability – 43:03 Manageme